No Detail Found!

Efect of diferent doses of Budesonide combined with Tiotropium bromide inhalation on elderly patients with chronic obstructive pulmonary disease

Author(s)
Jianhong Yu Department of Geriatric, Affiliated Hospital of Shaoxing University, 999 Zhongxing South Road, Shaoxing, Zhejiang Province 312000, P.R. China.
Jianchao Ni Department of Geriatric, Affiliated Hospital of Shaoxing University, 999 Zhongxing South Road, Shaoxing, Zhejiang Province 312000, P.R. China.
Xindong Chen Department of Geriatric, Affiliated Hospital of Shaoxing University, 999 Zhongxing South Road, Shaoxing, Zhejiang Province 312000, P.R. China.
Yuanyuan Fang Department of Geriatric, Affiliated Hospital of Shaoxing University, 999 Zhongxing South Road, Shaoxing, Zhejiang Province 312000, P.R. China.
Suna Fu Department of Geriatric, Affiliated Hospital of Shaoxing University, 999 Zhongxing South Road, Shaoxing, Zhejiang Province 312000, P.R. China.
Abstract
Objective: To explore the clinical efect of various doses of Budesonide combined with Tiotropium bromide in the treatment of elderly patients with chronic obstructive pulmonary disease (COPD). Methods: Clinical data of elderly patients with COPD, admitted to Afiliated Hospital of Shaoxing University from April 2021 to February 2023, were retrospectively analyzed. Based on the dosage of Budesonide combined with Tiotropium bromide, patients were divided into Low-dose group (Budesonide = 1mg), Medium-dose group (Budesonide = 2mg), and High-dose group (Budesonide = 3mg). All groups were matched for age, gender, course of disease, and BMI. Patients treated with Tiotropium bromide alone were assigned to the Control group. The clinical efect, pulmonary function index level, symptom improvement, inflammatory factor index level and adverse reactions in all groups were analyzed and compared. Results: A total of 88 patients were included in this study with 22 patients in each group. The total eficacy of Medium-dose (90.91%) and High-dose group (90.91%) was significantly higher than that of Low-dose group (63.64%) and the Control group (59.09%) (P<0.05). After the treatment, levels of pulmonary function, symptom improvement and inflammatory factors in the High-dose and the Medium-dose groups were better than those in the Low-dose group and the Control group. Pulmonary function, symptom improvement and levels of inflammatory factors was significantly better in the Low-dose group compared to the Control group (P<0.05). Conclusions: Budesonide combined with tiotropium bromide is better than tiotropium bromide alone in the treatment of elderly patients with COPD. Compared with low (1mg) dosage, medium (2mg) and high (3mg) dosage of budesonide are more efective in improving lung function, alleviating symptoms, reducing inflammatory response,, and are not associated with increased rate of adverse reactions.
Publication Details
Page(s) 1338-1344
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 7, Year: 2024

Request the full text from PASTIC

Keywords
Chronic Obstructive Pulmonary Disease, Budesonide, Tiotropium bromide, Diferent doses
0

Citations

0

Downloads

58

Views